At the beginning of this year, the Centers for Medicare & Medicaid Services (CMS) — a division of the U.S. Department of Health and Human Services — proposed a new rule in the Medicare Part D prescription drug program to crack down on what’s becoming an increasingly bigger issue in the U.S. healthcare industry: prescription fraud and abuse. Here is a look at the controversial rule and how it may impact your practice.
In April, the FDA opened a schism in the gynecologic oncology and pathology communities when it approved the Roche cobas human papilloma virus (HPV) Test as a primary screening tool for cervical cancer.
Election Day approaches and the ACA hangs in the balance.
The question of how best to identify and treat prostate cancer continues to trouble the medical community.
As the nation continues to mourn the children, teachers and school employees who lost their lives in Newtown, Conn., the American Academy of Pediatrics (AAP) is advocating for changes to ensure children are safe in their schools and communities. The Academy’s 60,000 members have a heartfelt desire to do everything possible to prevent a repeat of such tragedies.
- ‹ previous
- 2 of 2